RIDMAL TABLETS 6’S

Ridmal is a combination medication that contains Dihydroartemisinin (40 mg) and Piperaquine Phosphate (320 mg). It is primarily used for the treatment of uncomplicated malaria caused by Plasmodium falciparum, the most common and severe malaria parasite. Dihydroartemisinin is an artemisinin derivative that acts quickly to reduce the number of malaria parasites in the blood, while Piperaquine is an antimalarial that helps to eliminate the remaining parasites and prevent relapse.

This combination therapy is effective due to the synergistic action of both drugs, enhancing the overall efficacy and reducing the risk of resistance development. Ridmal is typically administered in a short course, making it a convenient option for patients. It is particularly useful in areas where malaria is endemic and is recommended for both adults and children, depending on the specific guidelines and recommendations in the region.